Absolute risk low, but findings may help inform treatment decisions, say researchers Use of glucagon-like peptide-1 (GLP-1) receptor agonists used to treat type 2 diabetes and obesity are associated with an increased…
0 comments
No comments yet.
Related stories
- Hacker News · 45 points · about 2 hours ago
- Mixing rayon and tokio for fun and (hair) lossblog.dureuill.netLobsters · 17 points · over 2 years ago
- Hacker News · 4 points · 7 days ago
- Hacker News · 1 points · 12 days ago
- Hacker News · 3 points · 5 days ago
- Show HN: Diabetes Risk Analyzer (Flask-based web app)diabetesriskanalyzer.orgHacker News · 1 points · 4 days ago